Philip Astley-Sparke
Fondatore presso REPLIMUNE GROUP, INC.
Patrimonio netto: 8 M $ in data 30/04/2024
Posizioni attive di Philip Astley-Sparke
Società | Posizione | Inizio | Fine |
---|---|---|---|
REPLIMUNE GROUP, INC. | Presidente | 01/04/2024 | - |
Fondatore | 01/03/2015 | - | |
Direttore/Membro del Consiglio | 01/03/2015 | 01/04/2024 | |
Amministratore Delegato | 09/01/2020 | 01/04/2024 | |
Segretario Aziendale | 01/03/2015 | - | |
Treasurer | 01/03/2015 | - | |
Forbion Capital Partners Management Holding BV
Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Investitore di Private Equity | 01/05/2012 | - |
Replimune Ltd.
Replimune Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Replimune Group, Inc., Replimune Ltd. is a British company that researches and develops cancer therapeutics. The company is based in Abingdon, UK and was founded in 2015. | Direttore/Membro del Consiglio | 18/03/2015 | - |
Storia della carriera di Philip Astley-Sparke
Precedenti posizioni note di Philip Astley-Sparke
Società | Posizione | Inizio | Fine |
---|---|---|---|
UNIQURE N.V. | Direttore/Membro del Consiglio | 01/06/2015 | 22/09/2016 |
Presidente | 22/09/2016 | 15/06/2021 | |
Independent Dir/Board Member | - | 15/06/2021 | |
Corporate Officer/Principal | 01/06/2013 | 22/09/2016 | |
Oxyrane, Ltd. | Presidente | 01/01/2012 | 01/01/2020 |
uniQure, Inc.
uniQure, Inc. BiotechnologyHealth Technology Part of uniQure NV, uniQure, Inc. provides research and development services of human gene based therapies. The company is based in Lexington, MA. | Presidente | 01/01/2013 | 01/02/2015 |
AMGEN INC. | Corporate Officer/Principal | - | 01/12/2011 |
BioVex, Inc.
BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Amministratore Delegato | 01/07/2000 | 31/03/2011 |
Presidente | 01/07/2000 | 31/03/2011 | |
FORN EUROPAR | Direttore/Membro del Consiglio | - | - |
Independent Dir/Board Member | - | - | |
░░░░░░ ░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░ | ░░░░░░░░░░ | - |
Formazione di Philip Astley-Sparke
University of Bristol | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 7 |
Regno Unito | 3 |
Germania | 2 |
Posizioni
Director/Board Member | 4 |
Chief Executive Officer | 3 |
President | 3 |
Settori
Health Technology | 7 |
Finance | 3 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
UNIQURE N.V. | Health Technology |
REPLIMUNE GROUP, INC. | Health Technology |
AMGEN INC. | Health Technology |
Aziende private | 7 |
---|---|
BioVex Group, Inc.
BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | Health Technology |
BioVex, Inc.
BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Health Technology |
Forbion Capital Partners Management Holding BV
Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Finance |
Replimune Ltd.
Replimune Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Replimune Group, Inc., Replimune Ltd. is a British company that researches and develops cancer therapeutics. The company is based in Abingdon, UK and was founded in 2015. | Commercial Services |
uniQure, Inc.
uniQure, Inc. BiotechnologyHealth Technology Part of uniQure NV, uniQure, Inc. provides research and development services of human gene based therapies. The company is based in Lexington, MA. | Health Technology |
Forbion European Acquisition Corp.
Forbion European Acquisition Corp. Financial ConglomeratesFinance Forbion European Acquisition Corp. is a blank check company. It engages in the business of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was founded by Hugo Alexander Slootweg in 2006 and is headquartered in Wilmington, DE. | Finance |
Oxyrane, Ltd. |
- Borsa valori
- Insiders
- Philip Astley-Sparke
- Esperienza